Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Artesunate/mefloquine - Drugs for Neglected Diseases Initiative Foundation

Next Previous
X
Search
Drug Profile

Artesunate/mefloquine - Drugs for Neglected Diseases Initiative Foundation

Alternative Names: Artesunate-mefloquine; ASMQ FDC; Mefliam Plus; Mefloquine/artesunate

Latest Information Update: 02 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Drugs for Neglected Diseases Initiative Foundation
  • Developer Cipla; Drugs for Neglected Diseases Initiative Foundation; Oswaldo Cruz Foundation
  • Class Antimalarials; Artemisinins; Phytotherapies; Quinolines; Sesquiterpenes
  • Mechanism of Action Free radical stimulants; Sarcoplasmic reticulum calcium-transporting ATPase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Falciparum malaria

Most Recent Events

  • 30 Jul 2019 No development reported - Preregistration for Falciparum malaria in Laos, Philippines, Papua New Guinea, Indonesia, Kenya, Ghana, Ghana, Togo, Benin, Chad, Ivory Coast, Guinea, Senegal, Senegal, Democratic Republic of the Congo, Democratic Republic of the Congo, Malawi, Congo, Mali (PO)
  • 19 May 2017 Artesunate/mefloquine is still pending registration for Falciparum malaria in Laos, Philippines, Papua New Guinea, Indonesia, Kenya, Ghana, Benin, Togo, Chad, Ivory Coast, Republic of Guinea, Senegal, Democratic Republic of Congo, Malawi, Congo, and Mali (PO) (DNDi website, May 2017)
  • 19 May 2017 Launched for Falciparum malaria in Cameroon and Thailand (PO) before May 2017 (DNDi website, May 2017)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top